These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 6133583

  • 1. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
    Thesleff S, Molgó J, Lundh H.
    Brain Res; 1983 Mar 28; 264(1):89-97. PubMed ID: 6133583
    [Abstract] [Full Text] [Related]

  • 2. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin.
    Kim YI, Lømo T, Lupa MT, Thesleff S.
    J Physiol; 1984 Nov 28; 356():587-99. PubMed ID: 6520797
    [Abstract] [Full Text] [Related]

  • 3. 4-aminoquinoline-induced 'giant' miniature endplate potentials at mammalian neuromuscular junctions.
    Molgó J, Thesleff S.
    Proc R Soc Lond B Biol Sci; 1982 Jan 22; 214(1195):229-44. PubMed ID: 6127680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.
    Molgó J, Siegel LS, Tabti N, Thesleff S.
    J Physiol; 1989 Apr 22; 411():195-205. PubMed ID: 2575665
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A new type of transmitter release at the neuromuscular junction.
    Thesleff S, Molgó J.
    Neuroscience; 1983 May 22; 9(1):1-8. PubMed ID: 6308500
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin.
    Dreyer F, Rosenberg F, Becker C, Bigalke H, Penner R.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan 22; 335(1):1-7. PubMed ID: 2883583
    [Abstract] [Full Text] [Related]

  • 13. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J, del Pozo E, Baños JE, Angaut-Petit D.
    Br J Pharmacol; 1991 Sep 22; 104(1):133-8. PubMed ID: 1686201
    [Abstract] [Full Text] [Related]

  • 14. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC, Thesleff S, Dasgupta BR.
    Acta Physiol Scand; 1983 Sep 22; 119(2):127-33. PubMed ID: 6140815
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction.
    Molgó J, Dasgupta BR, Thesleff S.
    Acta Physiol Scand; 1989 Dec 22; 137(4):497-501. PubMed ID: 2557728
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW.
    Muscle Nerve; 1982 Dec 22; 5(9S):S12-6. PubMed ID: 6302487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.